Giant ragweed specific immunotherapy is not effective in a proportion of patients sensitized to short ragweed: Analysis of the allergenic differences between short and giant ragweed

被引:25
作者
Asero, R
Weber, B
Mistrello, G
Amato, S
Madonini, E
Cromwell, O
机构
[1] Clin San Carlo, Ambulatorio Allergol, I-20037 Paderno Gugnano, MI, Italy
[2] Allergopharma, Reinbek, Italy
[3] Lofarma SpA, Milan, Italy
关键词
ragweed; allergy; cross-reactivity; specific immunotherapy; allergens;
D O I
10.1016/j.jaci.2005.08.019
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Short ragweed and giant ragweed pollen allergens are considered largely cross-reactive, and it is generally believed that I species is sufficient for skin testing and immunotherapy. However, in the area north of Milan (a zone widely invaded only by short ragweed), about 50% of patients submitted to injection specific immunotherapy with giant ragweed showed little or no clinical response, but showed an excellent outcome if they were shifted to short ragweed specific immunotherapy. Objective: To investigate allergenic differences between short and giant ragweed. Methods: IgE reactivity to short ragweed of sera from 16 patients allergic to ragweed was assessed by immunoblot before and after absorption with short and giant ragweed. Moreover, 41 ragweed-monosensitive patients underwent skin prick test with both ragweed species. Results: In several cases, preabsorption of sera with giant ragweed extract was unable to inhibit IgE reactivity fully against both a 43-kd allergen and other allergens at different molecular weights in short ragweed. On skin prick test, short ragweed induced larger wheals than giant ragweed in the majority of patients, and 6 of 41 (15%) patients were strongly short ragweed-positive but giant ragweed-negative. The immunoblot with the serum from I of these subjects showed a strong IgE reactivity to short ragweed at about 43 kd in the absence of any reactivity to giant ragweed. Conclusion: Short and giant ragweed are not allergenically equivalent. Allergenic differences involve both the major allergens Amb a 1-2/Amb t 1-2 and some minor allergens. In patients allergic to ragweed, both diagnosis in vivo and immunotherapy should always be performed by using the ragweed species present in that specific geographic area.
引用
收藏
页码:1036 / 1041
页数:6
相关论文
共 21 条
[1]   Birch and ragweed pollinosis north of Milan: a model to investigate the effects of exposure to "new" airborne allergens [J].
Asero, R .
ALLERGY, 2002, 57 (11) :1063-1066
[2]  
ASERO R, 1998, GIORN IT ALLERGOL IM, V8, P241
[3]   INVITRO CROSS-ALLERGENICITY OF MAJOR AEROALLERGENIC POLLENS BY RADIOALLERGOSORBENT TECHNIQUE [J].
BERNSTEIN, IL ;
PERERA, M ;
GALLAGHER, J ;
MICHAEL, JG ;
JOHANSSON, SGO .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1976, 57 (02) :141-152
[4]  
BOTTERO P, 1990, Folia Allergologica et Immunologica Clinica, V37, P99
[5]  
Bousquet J, 1998, ALLERGY, V53, P4
[6]   SPECIFIC IMMUNOTHERAPY WITH A STANDARDIZED DERMATOPHAGOIDES-PTERONYSSINUS EXTRACT .2. PREDICTION OF EFFICACY OF IMMUNOTHERAPY [J].
BOUSQUET, J ;
HEJJAOUI, A ;
CLAUZEL, AM ;
GUERIN, B ;
DHIVERT, H ;
SKASSABROCIEK, W ;
MICHEL, FB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 82 (06) :971-977
[7]  
Chapoval SP, 1998, J IMMUNOL, V161, P2032
[8]   POSITION PAPER - ALLERGEN STANDARDIZATION AND SKIN-TESTS [J].
DREBORG, S ;
FREW, A .
ALLERGY, 1993, 48 (14) :49-82
[9]   Long-term clinical efficacy of grass-pollen immunotherapy [J].
Durham, SR ;
Walker, SM ;
Varga, EM ;
Jacobson, MR ;
O'Brien, F ;
Noble, W ;
Till, SJ ;
Hamid, QA ;
Nouri-Aria, KT .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :468-475
[10]  
Esch R. E., 2003, ALLERGY PRINCIPLES P, P529